FilingReader Intelligence
Autobio receives $10m settlement from Mobidiag dispute
July 28, 2025 at 09:10 AM UTC•By FilingReader AI
Zhengzhou Autobio Diagnostics announced it received the full $10m settlement from Mobidiag Oy by July 25, 2025. The dispute stemmed from joint venture and licensing agreement issues.
The resolution is expected to positively impact Autobio's net profit for the relevant reporting period.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:603658•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Autobio Diagnostics publishes news
Free account required • Unsubscribe anytime